Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05566704 · ClinicalTrials.gov registry record

Retrospective Modulus ALIF Study

A clinical trial of Degenerative Disc Disease and Spondylolisthesis, sponsored by NuVasive.

Completed
Registry status
123
Enrollment target
5
Study locations

NCT05566704 is a study of Degenerative Disc Disease and Spondylolisthesis that has completed, run by NuVasive. The registered enrollment target is 123 participants, below the 166-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (26% lower). The trial reports 5 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05566704, a study of Degenerative Disc Disease and Spondylolisthesis, has completed, sponsored by NuVasive.

COMPLETED
Registry status
123 participants
Enrollment target
5
Study locations

Study Summary

The primary objective of this study is to evaluate the safety and performance of the Modulus ALIF System in patients undergoing anterior lumbar interbody fusion (ALIF) as measured by reported complications, radiographic outcomes, and patient-reported outcomes.

Interventions

  • DEVICE Modulus ALIF System

Study Locations (5)

California

  • Hoag Orthopedics - Orange
  • Girard Orthopedic Surgeons - San Diego

North Carolina

  • OrthoCarolina - Charlotte
  • Atlantic Brain and Spine - Wilmington

Georgia

  • Georgia Spine & Neurosurgery Center - Atlanta

Trial Details

FieldValue
Enrollment Target 123 participants
Start Date 2022-08-18
Est. Completion 2024-05-01

Sponsor

NuVasive

28 total trials

What the Registry Record Tells You About NCT05566704

The ClinicalTrials.gov registry entry for NCT05566704 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 166-participant average among 42 other Degenerative Disc Disease trials with a reported enrollment target (26% lower). The listed sponsor is NuVasive, which has 28 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Degenerative Disc Disease appearing as the primary indexed condition, and to 1 intervention - of which Modulus ALIF System is the first listed.

NCT05566704 reports 5 study locations spanning 3 distinct geographic areas - top geographies include California, North Carolina, Georgia.

Frequently Asked Questions

What is clinical trial NCT05566704 about?

NCT05566704 is a clinical study titled "Retrospective Modulus ALIF Study". The primary objective of this study is to evaluate the safety and performance of the Modulus ALIF System in patients undergoing anterior lumbar interbody fusion (ALIF) as measured by reported complications, radiographic outcomes, and patient-reported outcomes.

What is the current status of trial NCT05566704?

This trial is currently completed. The enrollment target is 123 participants. The study started on 2022-08-18. Estimated completion is 2024-05-01.

What conditions does trial NCT05566704 study?

This clinical trial studies the following conditions: Degenerative Disc Disease, Spondylolisthesis, Stenosis.

What interventions are being tested in trial NCT05566704?

The interventions under investigation include: Modulus ALIF System (DEVICE).

Who is sponsoring clinical trial NCT05566704?

This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05566704 being conducted?

This trial has 5 study locations across California, Georgia, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Degenerative Disc Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.